다중혈관 관상동맥 환자에서 y-문합을 이용하여 양쪽 내흉동맥만을 사용한 우회술의 조기 성적

The 11th edition of Harrison's Principles of Internal Medicine welcomes Anthony Fauci to its editorial staff, in addition to more than 85 new contributors. While the organization of the book is similar to previous editions, major emphasis has been placed on disorders that affect multiple organ systems. Important advances in genetics, immunology, and oncology are emphasized. Many chapters of the book have been rewritten and describe major advances in internal medicine. Subjects that received only a paragraph or two of attention in previous editions are now covered in entire chapters. Among the chapters that have been extensively revised are the chapters on infections in the compromised host, on skin rashes in infections, on many of the viral infections, including cytomegalovirus and Epstein-Barr virus, on sexually transmitted diseases, on diabetes mellitus, on disorders of bone and mineral metabolism, and on lymphadenopathy and splenomegaly. The major revisions in these chapters and many

Harrison's Principles of Internal Medicine

비만아 부모의 돌봄 경험: q 방법론

Impact of COVID-19 pandemic on mental health in the general population: A systematic review.

https://www.commed.vcu.edu/Chronic_Disease/2012/cochranrvwrschbias.pdf

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

/pdf/comparison-the-effect-of-calcium-sulfate-and-ferric-chloride-rr9thl7c6w.pdf

Comparison the Effect of Calcium Sulfate and Ferric Chloride in Controlling Liver Bleeding an Animal Model Study

هدیکچ فده و هقباس : تفای نیرتعیاش یویر یلوبمآ رد ه تسا تسار نطب ییاسران . تـیزم و عویـش یـسررب هعلاطم نیا فده نینوپورت یصیخشت یبلق I رد ت خش ی طب ییاسران هب لاتبم نارامیب ص ن یم هیر یلوبمآ لیلدب تسار دشاب . اه شور و داوم : هعلاطم نیا یور 42 ا نادـمه رهـش ناـتبکا ناتـسرامیب رد یوـیر یلوـبمآ هـب لاتـبم راـمیب ماـجن دـش . زا مزلا تاعلاطا نتفرگ قیرط ،نارامیب لاح حرش ماجنا یویر نژویفرپ نکسا و مارگویدراکوکا عـمج دـش یروآ هـنومن و یاـه ب نارامیب نوخ ه یویر یلوبمآ صیخشت زا دعب تعرس دش هتفرگ نینوپورت و I یفارگوتامورک شور اب هزادنا یریگ دیدرگ . اه هتفای : نینوپورت I رد 2 ا دروم هـتفای شیازـف دوـب ، ) یلااـب g/l μ 5 / 0 ( رد و 40 دروـم ) 2 / 95 دـصرد ( زا رـتمک g/l μ 5 / 0 دوب . رد تسار نطب درکلمع للاتخا 16 ) 38 دصرد ( دش هدهاشم رامیب . نـطب درـکلمع للاتخا کیفارگویدراکوکا مئلاع نینوپورت اب رامیب ود زا رامیب کی رد تسار I رد و تبثم 15 زا رامیب 40 رامیب ) 5 / 37 دصرد ( اب دـش هدهاشـم یفنم نینوپورت . نینوپرت حطس و تسار نطب ییاسران نیب یطابترا چیه I دیدرگن تفای . جاتنتسا : نینوپورت نتفر لااب I هیر داح یلوبمآ رد مغرـیلع نآ نییاـپ عویـش ، ناشـن هدـنهد هـک تـسا نآ هزادـنا یرـیگ نینوپورت I یمن للع زا هنیس درد یبلق للع قارتفا هب دناوت کمک تسار نطب درکلمع للاتخا صیخشت و نآ یبلقریغ ینادنچ دیامن .

/pdf/assessment-of-cardiac-troponin-i-in-patients-with-pulmonary-170hi38rel.pdf

Assessment of cardiac troponin I in patients with pulmonary emboli and its relationship with right ventricular dysfunction.

Background: Asthma is the most chronic inflammatory disease of the airways worldwide. Combination therapy with inhaled fluticasone and salmeterol is a common practice for the long-term management of asthma. Seretide® and Fluticort plus® are two available generic and brand name products of salmeterol/fluticasone. This study aimed to compare the efficacy and safety of these two drugs. Materials and Methods: In this randomized comparative, clinical trial, 80 asthmatic patients were allocated to Fluticort plus® (n=40) or Seretide® (n=40) for a period of 4 weeks. Patients with mild asthma were instructed to inhale one puff each 12 hours and those with moderate asthma two puffs every 12 hours. Respiratory volumes (assessed using spirometry), quality of life (assessed using St. George’s Respiratory Questionnaire [SGRQ]) and control of asthmatic symptoms (assessed using asthma control test [ACT]) were evaluated at baseline and at the end of the study. Results: ACT score improved only in the Fluticort plus® group (p=0.012) while it was not significantly changed in the Seretide® group (p=0.178). In both treatment groups, FEV1, FEV1/FVC, and total as well as subscale SGRQ scores were significantly improved by the end of the study (p<0.05). Seretide® more efficiently improved respiratory volumes and SGRQ score in comparison with Fluticort plus® (p<0.05). Conclusion: Our comparative trial indicated that generic fluticasone/salmeterol product could improve respiratory volumes, quality of life but its efficacy is lower than the brand-name product. However, Fluticort plus® improved asthma control more efficiently compared with Seretide®. (www.actabiomedica.it)

Investigation of the efficacy of generic and brand-name salmeterol/fluticasone combination in the management of asthma: a randomized comparative trial.

Various severe acute respiratory syndrome coronavirus 2 vaccines with different platforms have been administered worldwide; however, their effectiveness in critical cases of COVID‐19 has remained a concern. In this national cohort study, 24 016 intensive care unit (ICU) coronavirus disease‐2019 (COVID‐19) admissions were included from January to April 2022. The mortality and length of ICU stay were compared between the vaccinated and unvaccinated patients. A total of 9428 (39.25%) patients were unvaccinated, and 14 588 (60.75%) patients had received at least one dose of the vaccine. Compared with the unvaccinated, the first, second, and third doses of vaccine resulted in 8%, 20%, and 33% lower risk of ICU mortality in the adjusted model, with risk ratio (RR): 0.92, 95% confidence interval (CI): 0.84–1.001, RR: 0.80, 95% CI: 0.77–0.83, and RR: 0.67, 95% CI: 0.64–0.71, respectively. The mean survival time was significantly shorter in the unvaccinated versus the fully vaccinated patients (hazard ratio [HR]: 0.84, 95% CI: 0.80–0.88); p < 0.001). All vaccine platforms successfully decreased the hazard of ICU death compared with the unvaccinated group. The duration of ICU stay was significantly shorter in the fully vaccinated than in unvaccinated group (MD, −0.62, 95% CI: −0.82 to −0.42; p < 0.001). Since COVID‐19 vaccination in all doses and platforms has been able to reduce the risk of mortality and length of ICU‐stay, universal vaccination is recommended based on vaccine availability.

Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID‐19 in the Omicron variant era: A national cohort study in Iran

Yunes Panahi

Papers

Comparison the Effect of Calcium Sulfate and Ferric Chloride in Controlling Liver Bleeding an Animal Model Study

Assessment of cardiac troponin I in patients with pulmonary emboli and its relationship with right ventricular dysfunction.

Investigation of the efficacy of generic and brand-name salmeterol/fluticasone combination in the management of asthma: a randomized comparative trial.

Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID‐19 in the Omicron variant era: A national cohort study in Iran

Asthma can Promote Cardiomyocyte Mitophagy in a Rat Model